Home > Qtrly Results > NEULAND LABORATORIES

NEULAND LABORATORIES
Quarterly Results Analysis [Dec2024]

NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Quarterly Results

Consolidated Dec2024
UnAudited
Sep2024
UnAudited
Jun2024
UnAudited
Mar2024
UnAudited
Dec2023
UnAudited
Sep2023
Audited
Jun2023
UnAudited
Mar2023
Audited
Revenues ₹398 Cr ₹311 Cr ₹440 Cr ₹385 Cr ₹393 Cr ₹418 Cr ₹363 Cr ₹407 Cr
Expenses ₹311 Cr ₹249 Cr ₹316 Cr ₹278 Cr ₹272 Cr ₹280 Cr ₹266 Cr ₹287 Cr
Operating Income ₹87 Cr ₹62 Cr ₹123 Cr ₹107 Cr ₹121 Cr ₹137 Cr ₹97 Cr ₹120 Cr
Other Income ₹4 Cr ₹4 Cr ₹5 Cr ₹5 Cr ₹2 Cr ₹3 Cr ₹2 Cr ₹8 Cr
Interest ₹2 Cr ₹1 Cr ₹3 Cr ₹4 Cr ₹4 Cr ₹4 Cr ₹2 Cr ₹4 Cr
Depreciation ₹16 Cr ₹16 Cr ₹16 Cr ₹16 Cr ₹15 Cr ₹15 Cr ₹14 Cr ₹13 Cr
Profit Before Tax ₹128 Cr ₹49 Cr ₹130 Cr ₹92 Cr ₹104 Cr ₹122 Cr ₹83 Cr ₹110 Cr
Profit After Tax ₹102 Cr ₹33 Cr ₹98 Cr ₹68 Cr ₹81 Cr ₹89 Cr ₹62 Cr ₹85 Cr
EPS ₹78.75 ₹25.46 ₹75.86 ₹52.37 ₹63.09 ₹69.18 ₹47.96 ₹65.53
Industry Peers & Returns1W1M1Y
NEULAND LABORATORIES -7.9% 2.8% 116.5%
SUN PHARMACEUTICAL INDUSTRIES -3.1% -3.9% 12.9%
CIPLA 1.1% 0.3% 1.4%
DR REDDYS LABORATORIES -1.3% -9.4% -0.8%
ZYDUS LIFESCIENCES -3.7% -5.9% 19.7%
DIVIS LABORATORIES -2.9% -0.8% 62.5%
MANKIND PHARMA -1.3% -8.2% 11.8%
TORRENT PHARMACEUTICALS -0.4% -4.6% 20.1%
LUPIN -5.5% -4.1% 33.9%

NEULAND LABORATORIES Quarterly Revenues

Revenues
Q-o-Q

28.05 %

Y-o-Y

1.32 %

Quarters Revenues % Change
Dec2024 ₹398 Cr
28.05
Sep2024 ₹311 Cr
-29.29
Jun2024 ₹440 Cr
14.18
Mar2024 ₹385 Cr
-1.99
Dec2023 ₹393 Cr
-5.97
Sep2023 ₹418 Cr
15.08
Jun2023 ₹363 Cr
-10.83
Mar2023 ₹407 Cr -

NEULAND LABORATORIES Quarterly Operating Profit

Operating Profit
Q-o-Q

39.16 %

Y-o-Y

-28.59 %

Quarters Operating Profit % Change
Dec2024 ₹87 Cr
39.16
Sep2024 ₹62 Cr
-49.56
Jun2024 ₹123 Cr
15.38
Mar2024 ₹107 Cr
-11.83
Dec2023 ₹121 Cr
-11.80
Sep2023 ₹137 Cr
41.86
Jun2023 ₹97 Cr
-19.14
Mar2023 ₹120 Cr -
Operating Margins
Q-o-Q

8.69 %

Y-o-Y

-29.51 %

Quarters Operating Margin% % Change
Dec2024 21.76%
8.69
Sep2024 20.02%
-28.65
Jun2024 28.06%
1.04
Mar2024 27.77%
-10.04
Dec2023 30.87%
-6.20
Sep2023 32.91%
23.26
Jun2023 26.7%
-9.31
Mar2023 29.44% -

NEULAND LABORATORIES Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

209.32 %

Y-o-Y

24.82 %

Quarters Profit After Tax % Change
Dec2024 ₹102 Cr
209.32
Sep2024 ₹33 Cr
-66.44
Jun2024 ₹98 Cr
44.86
Mar2024 ₹68 Cr
-16.99
Dec2023 ₹81 Cr
-8.80
Sep2023 ₹89 Cr
44.23
Jun2023 ₹62 Cr
-26.81
Mar2023 ₹85 Cr -
PAT Margins
Q-o-Q

141.44 %

Y-o-Y

23.17 %

Quarters PAT Margin(%) % Change
Dec2024 25.52 %
141.44
Sep2024 10.57 %
-52.52
Jun2024 22.26 %
26.84
Mar2024 17.55 %
-15.30
Dec2023 20.72 %
-3.00
Sep2023 21.36 %
25.28
Jun2023 17.05 %
-17.91
Mar2023 20.77 % -

NEULAND LABORATORIES Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

209.31 %

Y-o-Y

24.82 %

Quarters EPS % Change
Dec2024 ₹78.75
209.31
Sep2024 ₹25.46
-66.44
Jun2024 ₹75.86
44.85
Mar2024 ₹52.37
-16.99
Dec2023 ₹63.09
-8.80
Sep2023 ₹69.18
44.25
Jun2023 ₹47.96
-26.81
Mar2023 ₹65.53 -

You may also like the below Video Courses